| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AIMMUNE THERAPEUTICS INC COM | 3,967,900 | 42,933,000 | 29.35% | ||
| 2 | UNIVERSAL AMERN CORP NEW | 2,814,883 | 21,337,000 | 14.59% | ||
| 3 | AERIE PHARMACEUTICALS INC | 975,285 | 17,165,000 | 11.73% | ||
| 4 | ALDER BIOPHARMACEUTICALS INC | 600,929 | 15,005,000 | 10.26% | ||
| 5 | EPIZYME INC COM | 1,191,995 | 12,206,000 | 8.34% | ||
| 6 | NANOSTRING TECHNOLOGIES INC | 727,857 | 9,171,000 | 6.27% | ||
| 7 | ADAPTIMMUNE THERAPEUTICS PLC | 1,054,864 | 8,597,000 | 5.88% | ||
| 8 | ZAFGEN INC COM | 760,046 | 4,553,000 | 3.11% | ||
| 9 | NEXVET BIOPHARMA PUB LTD CO | 900,155 | 4,177,000 | 2.86% | ||
| 10 | ARDELYX INC COM | 428,989 | 3,745,000 | 2.56% | ||
| 11 | Orexigen Therapeutics, Inc. | 5,427,559 | 2,334,000 | 1.60% | ||
| 12 | ACCELERON PHARMA | 48,839 | 1,660,000 | 1.13% | ||
| 13 | NEURODERM LTD | 83,211 | 1,352,000 | 0.92% | ||
| 14 | REGENXBIO INC COM | 156,741 | 1,254,000 | 0.86% | ||
| 15 | BioDelivery Sciences International Inc | 335,239 | 791,000 | 0.54% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-118725, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
